Biotech executives reveal 4 strategies they use to convince health insurers to cover new drugs
|02/12/2020||Posted by BusinessMediaguide.Com under General World News||
- Small and mid-size biotech companies are increasingly launching the drugs they develop, rather than getting added to the portfolios of larger pharmaceutical companies with established teams to sell the drugs.
- Launching a drug successfully — that is, getting insurers to cover the cost of the new treatment — isn’t as easy as proving the drug is safe and effective. Often, governments and private insurers require more evidence that it’s worth it to pay for the drug.
- Business Insider spoke to biotech executives at the BIO CEO & Investor Conference in New York on Monday to break down what all companies need read more >>>